HK1001670B - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- HK1001670B HK1001670B HK98100745.1A HK98100745A HK1001670B HK 1001670 B HK1001670 B HK 1001670B HK 98100745 A HK98100745 A HK 98100745A HK 1001670 B HK1001670 B HK 1001670B
- Authority
- HK
- Hong Kong
- Prior art keywords
- cetylpyridinium chloride
- teeth
- adsorption
- amino acid
- salt
- Prior art date
Links
Description
The present invention relates to the use of cetylpyridinium and an Nα-longer acyl basic amino acid lower alkyl ester or salt thereof for the preparation of a composition for the oral cavity, wherein adsorption of cetylpyridinium chloride as a bactericide to the surfaces of teeth is promoted.
Dental plaque is formed by adsorption and propagation of intraoral bacteria such as Streptococcus mutans and the like on the surfaces of teeth. It is well known that dental plaque is the cause of dental caries and is also the cause of gingivatis or alveolar pyorrhea. Therefore, it is important to remove dental plaque and to prevent adhesion of it (plaque control) for oral sanitation.
Among the plaque control methods, the method which is conducted most popularly is that for removing dental plaque mechanically by brushing, that is, by using a toothbrush. However, in order to remove dental plaque completely by brushing, high-level brushing technique is needed. In practice, almost all of peoples are conducting insufficient brushing and, therefore, the rate of diseases such as dental caries, gingivatis and alveolar pyorrhea is not reduced despite of conducting brushing.
Accordingly, in order to compensate brushing, or to substitute for brushing, a chemical plaque control method has been studied. The pyridinium compounds having C₈₋₁₈ straight or blanched chain alkyl group are famous. Among them, the compound of which efficacy and safety are clinically admitted is cetylpyridinium chloride.
It is known that cetylpyridinium chloride is a compound represented by the formula:
and it has a bactericidal action and is relatively liable to be adsorbed to oral mucosa or the surfaces of teeth. Thereby, it is considered that adsorption of intraoral bacteria to the surfaces of teeth is prevented and, further, formation of dental plaque is prevented. However, a study on promoting adsorption of such cetylpyridinium chloride to the surfaces of teeth and improving it's effect has not been found yet.
EP-A 0422 803 and EP-A 0 924 222 disclose an oral composition comprising cetylpyridinium chloride as an antibacterial agent and Nα-cocoyl-L-arginine ethyl ester pyrrolidone carboxylate as a cationic surfactant. GB-A 132 420 describes the antimicrobial and germicidal properties of lower alkyl esters of mono-N-higher aliphatic acyl arginine.
The present inventors have intensively studied to promote remaining of cetylpyridinium chloride in the oral cavity, particularly adsorption of it to the surfaces of teeth and to enhance the effect for preventing formation of bacterial plaque. As a result, it has been found that, when cetylpyridinium chloride is used in combination with an Nα-longer acyl basic amino acid lower alkyl ester or a salt thereof, adsorption of cetylpyridinium chloride to the surfaces of teeth is extremely promoted. Thus, the present invention has been completed.
According to the present invention, there is provided an oral composition comprising cetylpyridinium chloride and a Nα-longer acyl basic amino acid lower alkyl ester or a salt thereof. According to the present invention, an oral composition which promotes adsorption of cetylpyridinium chloride to the surfaces of teeth and has excellent effect for preventing formation of dental plaque and dental caries can be obtained.
Cetylpyridinium chloride is normally formulated into the composition in an amount of more than 0.002 % by weight, preferably more than 0.01 % by weight. In view of bactericidal effect, the upper limit of the amount of cetylpyridinium chloride is not specifically limited. Considering the fact that cetylpyridinium chloride has a bitter taste and is likely to color teeth when the amount is too large, or influence on oral mucosa and the like, it is normally preferred that the amount is less than 1 % by weight.
As the basic amino acid part of the Nα-longer acyl basic amino acid lower alkyl ester to be used, ornithine, lysine and arginine are particularly preferred and it may be either an optical isomer or laceme thereof. The acyl group thereof is a saturated or unsaturated natural or synthetic fatty acid residue having 8 to 22 carbon atoms, for example, it may be a natural system mixed fatty acid residue such as coconut oil fatty acid, tallow fatty acid residue and the like, in addition to a monofatty acid residue such as lauroyl, myristyl, stearoyl group and the like. Further, it may also be a lower alkyl ester, and methyl ester, ethyl ester and propyl ester are suitable.
Examples of the salt of such the Nα-longer basic amino acid lower alkyl ester include an inorganic acid salt such as hydrochloride, sulfate, etc. or an organic acid salt such as acetate, tartrate, citrate, p-toluenesulfonate, fatty acid salt, acidic amino acid salt, etc. Among them, glutamate, pyroglutamate, acetate and citrate are preferred.
In the present invention, the Nα-longer basic amino acid lower alkyl ester or a salt thereof is that which promotes adsorption of cetylpyridinium chloride to the surfaces of teeth. The weight ratio thereof is at least 1/5, normally 1/5 to 10 based on the weight of cetylpyridinium chloride. When the ratio is too small, an effect for promoting adsorption of cetylpyridinium chloride to teeth becomes insufficient.
The oral composition of the present invention can be prepared in the form of tooth powder, dentifrice, mouthwash, troches and the like by formulating desired ingredients according to a conventional method and, further, it can be sprayed in the oral cavity as an aerosol. Further, it can be used for a liniment and also used after it was impregnated in a dental floss or toothpick.
The other ingredients formulated may be any ingredients which can be used in this kind of compositions in so far as they do not inhibit adsorption of cetylpyridinium chloride to the surfaces of teeth and it's bactericidal action. In the case of using vesicants or solubilizers, anionic ingredients are not preferred. It has been found that, when using nonionic or cationic ingredients, particularly, polyoxyethylene polyoxypropylene glycol, ethylenediaminetetrapolyoxyethylene polyoxypropylene glycol and the like, the effect of cetylpyridinium chloride is further improved.
In Experiments and Examples, all percentages are by weight unless otherwise stated.
The composition of enamel of the surfaces of teeth consists of inorganic mineral (97 %), organic material (1%) and water content (2 %), and a main ingredient of the mineral is calcium phosphate which is referred to as hydroxyapatite [Ca₁₀(PO₄)₆(OH)₂].
As a model of enamel of teeth, that obtained by dipping a hydroxyapatite disc [Bio-Gel HTP manufactured by Bio. Rad. Laboratories Co., U.S.A., 13 mmφ x 250 mg; prepared by making tablets at 150 kg/cm² and sintering at 600°C for 6 hours] in human saliva at 37°C for 18 hours was used. By dipping in saliva, saliva mucoprotein, etc. was adsorbed to the surface of hydroxyapatite to be allowed to simulate an actual state of tooth enamel wetted with saliva. This hydroxyapatite disc treated with saliva was placed in a test tube, followed by the addition of an aqueous 0.05 % cetylpyridinium chloride (manufactured by Merck Co.) solution (1 ml) and shaking at 37°C for 30 minutes. Thereafter, it was washed with water (6 ml) and extracted with an extraction solvent [50 mM sodium lauryl sulfate, 40 mM citrate buffer (pH 3.0)/acetonitrile = 30/70] to form a sample for high speed liquid chromatography. In the case of high speed liquid chromatography, Lichrosorb RP select B (4.0 mmφ x 250 mm) was used as a separation column and a extraction solvent was used as an eluent. The flow rate was 1 ml/minutes and detection of cetylpyridinium was conducted by measuring absorbance with 258 nm. Further, by using a calibration curve made by a standard solution of cetylpyridinium chloride, the amount of cetylpyridinium chloride was determined.
Likewise, after an apatite disc treated with saliva was dipped in a mixed solution in which various additives as shown in Table 1 were added to 0.05 % cetylpyridinium chloride in an amount of 0.1 %, respectively, the amount of cetylpyridinium chloride was determined. Further, regarding Nα-cocoyl-L-arginine ethyl ester pyrrolidone carboxylate among the additives which showed the effect for enhancing the amount of cetylpyridinium chloride adsorbed on the apatite disc, by varying in amount between 0.005, 0.01 and 0.05 %, respectively, the influence of the concentration on the amount of cetylpyridinium chloride adsorbed was confirmed. The results are also shown in Table 1. Table 1
| Compound | Amount of cetylpyridinium chloride (»g/disc) | |
| Initial | After 3 hours | |
| 0.05 % Cetylpyridinium chloride | 170 | 63 |
| 411 | 321 | |
| 436 | 336 | |
| 438 | 346 | |
| 424 | 330 | |
| 59 | 18 | |
| 173 | 60 | |
| 175 | 119 | |
| 331 | 242 | |
| 392 | 294 | |
As is shown in Table 1, when a Nα-longer acyl basic amino acid lower alkyl ester is formulated, cetylpyridinium chloride is specifically adsorbed to the hydroxyapatite disc and it is necessary that the weight ratio is more than 1/5 based on the weight of cetylpyridinium chloride.
Since cetylpyridinium chloride is sometimes inactivated in the case of forming a salt with an acidic substance, retention of bactericidal activity was also tested as follows.
Regarding a sample wherein adsorption of cetylpyridinium chloride to the hydroxyapatite disc was enhanced by adding the Nα-longer acyl basic amino acid lower alkyl ester, a disc was suspended to a 5 % sucrose BHI medium. Then, one loopful of the Streptococcus mutans ATCC 25175 strain was inoculated and cultivated at 37°C for 18 hours. As a result, adhesion of plaque to the hydroxyapatite disc was not observed and it was confirmed that cetylpyridinium chloride adsorbed on the hydroxyapatite disc retains bactericidal activity.
According to the following formulation, a toothpaste was prepared by degassing, kneading and stirring according to a conventional method.
| Ingredients | % by weight |
| Calcium hydrogenphosphate | 20.0 |
| Polyoxyethylene polyoxypropylene glycol | 30.0 |
| Glycerin | 10.0 |
| Cetylpyridinium chloride | 0.1 |
| 0.05 | |
| Saccharin sodium | 0.2 |
| Flavor | 1.0 |
| Distilled water | up to 100 % |
According to the following formulation, a toothpaste was prepared by degassing, kneading and stirring according to a conventional method.
| Ingredients | % by weight |
| Calcium carbonate | 35.0 |
| Hydroxyethylcellulose | 1.5 |
| Ethylenediamine tetrapolyoxyethylene polyoxypropylene glycol | 5.0 |
| Sorbitol | 30.0 |
| Cetylpyridinium chloride | 0.01 |
| 0.01 | |
| Saccharin sodium | 0.1 |
| Flavor | 1.0 |
| Distilled water | up to 100 % |
According to the following formulation, a liquid mouthwash was prepared by mixing with stirring according to a conventional method.
| Ingredients | % by weight |
| Ethanol | 10.0 |
| Glycerin | 10.0 |
| Polyoxyethylene polyoxypropylene glycol | 1.5 |
| Saccharin sodium | 0.02 |
| Cetylpyridinium chloride | 0.05 |
| 0.1 | |
| Flavor | 0.3 |
| Distilled water | up to 100 % |
A yarn of 630 deniers comprising a plural of fine denier filaments of 6,6-nylon being twisted was dipped in the mixed solution of the following formulation, passed through a drying tube at 50°C and spooled with vaporizing ethanol to produce a dental floss.
| Ingredients | % by weight |
| Cetylpyridinium chloride | 5.0 |
| 10.0 | |
| Ethanol | 85.0 |
Claims (1)
- Use of cetylpyridinium chloride and an Nα-C₈ to C₂₂ acyl basic amino acid methyl, ethyl or propyl ester or salt thereof for the preparation of an oral composition, whereby the Nα-C₈ to C₂₂ acyl basic amino acid methyl, ethyl or propyl ester or salt thereof promotes the adsorption of said cetylpyridinium chloride to the surface of the teeth.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2139125A JPH0684294B2 (en) | 1990-05-29 | 1990-05-29 | Oral composition |
| JP139125/90 | 1990-05-29 | ||
| PCT/JP1991/000691 WO1991018585A1 (en) | 1990-05-29 | 1991-05-23 | Oral composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1001670B true HK1001670B (en) | 1998-07-03 |
| HK1001670A1 HK1001670A1 (en) | 1998-07-03 |
Family
ID=15238097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98100745A HK1001670A1 (en) | 1990-05-29 | 1991-05-23 | Oral composition |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5266306A (en) |
| EP (1) | EP0485616B1 (en) |
| JP (1) | JPH0684294B2 (en) |
| KR (1) | KR0167019B1 (en) |
| CN (1) | CN1069189C (en) |
| AT (1) | ATE126051T1 (en) |
| AU (1) | AU633217B2 (en) |
| CA (1) | CA2060895C (en) |
| DE (1) | DE69111985T2 (en) |
| DK (1) | DK0485616T3 (en) |
| ES (1) | ES2078523T3 (en) |
| GR (1) | GR3017090T3 (en) |
| HK (1) | HK1001670A1 (en) |
| MY (1) | MY106151A (en) |
| WO (1) | WO1991018585A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI942765L (en) * | 1991-12-11 | 1994-06-10 | Procter & Gamble | Cetylpyridinium chloride and domiphene bromide in an organic solvent |
| CN1034417C (en) * | 1992-12-04 | 1997-04-02 | 福州人造板厂 | Urea-formaldehyde resin for middle density fibre board use and preparing process |
| CN1112592C (en) * | 1994-08-05 | 2003-06-25 | 阿波罗·阿尔杰布拉(直布罗陀)有限公司 | Tactile-acoustic information detection and measurement device and method |
| GB9611364D0 (en) * | 1996-05-31 | 1996-08-07 | Smithkline Beecham Plc | Composition |
| US5948390A (en) * | 1997-08-25 | 1999-09-07 | Pfizer Inc. | Stable zinc/citrate/CPC oral rinse formulations |
| US5874068A (en) * | 1997-12-08 | 1999-02-23 | Warner-Lambert Company | Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts |
| KR100308247B1 (en) * | 1999-03-12 | 2001-09-26 | 신창국 | Compositions for cleaning oral cavity |
| KR100630512B1 (en) * | 2000-06-13 | 2006-09-29 | 주식회사 엘지생활건강 | Mouthwash Composition for the Prevention and Treatment of Colds and Sore throat |
| WO2002031105A1 (en) * | 2000-10-12 | 2002-04-18 | Sapporo Immuno Diagnostic Laboratory | Method and instrument for collecting fluid in the oral cavity |
| CN100403005C (en) | 2001-04-20 | 2008-07-16 | 札幌免疫诊断研究所 | Device for sampling and recovering oral secretion |
| CA2455983C (en) | 2001-08-09 | 2010-06-01 | Joan Baptista Urgell Beltran | Preservative systems and their use in cosmetic preparations |
| US8388986B2 (en) | 2001-08-09 | 2013-03-05 | Laboratorios Miret S.A. | Use of cationic surfactants in cosmetic preparations |
| PT1437946E (en) | 2001-10-25 | 2012-07-25 | Miret Lab | USE OF A COTTON PRESERVE IN FOOD PRODUCTS |
| CA2467244C (en) * | 2001-11-15 | 2011-01-04 | Laboratorios Miret S.A. | Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care |
| US6579513B1 (en) | 2002-01-03 | 2003-06-17 | Playtex Products, Inc. | Hygiene mouthspray composition |
| ATE408702T1 (en) | 2002-02-01 | 2008-10-15 | Miret Lab | ENZYMATIC SYNTHESIS OF N(ALPHA)-ACYL-L-ARGININE ESTERS |
| MXPA04010976A (en) | 2002-05-08 | 2005-01-25 | Miret Lab | New preservatives and protective systems. |
| US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
| US6946119B2 (en) * | 2003-02-14 | 2005-09-20 | J.M. Huber Corporation | Precipitated silica product with low surface area, dentifrices containing same, and processes |
| US20040258632A1 (en) * | 2003-06-23 | 2004-12-23 | Boyd Thomas J. | Stable aqueous antiplaque oral compositions |
| US8287843B2 (en) | 2003-06-23 | 2012-10-16 | Colgate-Palmolive Company | Antiplaque oral care compositions |
| EP1635774B2 (en) | 2003-06-23 | 2011-01-26 | Colgate-Palmolive Company | Stable dentifrice compositions |
| US20040258629A1 (en) * | 2003-06-23 | 2004-12-23 | Boyd Thomas J. | Antiplaque confectionery dental composition |
| DK1663122T3 (en) * | 2003-06-23 | 2010-06-07 | Colgate Palmolive Co | Mouthwash compositions containing N-acyl-arginine alkyl ester salts |
| US9241885B2 (en) * | 2004-01-29 | 2016-01-26 | The Procter & Gamble Company | Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials |
| US20070014740A1 (en) * | 2005-07-15 | 2007-01-18 | Colgate-Palmolive Company | Oral compositions having cationic active ingredients |
| US20080260836A1 (en) * | 2007-04-18 | 2008-10-23 | Thomas James Boyd | Films Comprising a Plurality of Polymers |
| MY154018A (en) | 2008-02-08 | 2015-04-30 | Colgate Palmolive Co | Dental floss |
| WO2012008410A1 (en) | 2010-07-12 | 2012-01-19 | 花王株式会社 | Toothpaste composition |
| CN102416011A (en) * | 2011-10-10 | 2012-04-18 | 艾硕特生物科技(昆明)有限公司 | Broad-spectrum and high-efficiency antibacterial lotion |
| EP4106716B1 (en) | 2020-02-18 | 2026-01-28 | Sunstar Americas, Inc. | Oral care composition |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL104948C (en) * | 1952-02-15 | |||
| US2772203A (en) * | 1952-04-03 | 1956-11-27 | Colgate Palmolive Co | Stable dental creams containing higher aliphatic acyl amide of aminocarboxxylic acid compound |
| US2757125A (en) * | 1952-05-16 | 1956-07-31 | Colgate Palmolive Co | N-higher alkyl-4-carboxy-2-pyrrolidones and compositions therewith |
| US2772204A (en) * | 1954-09-13 | 1956-11-27 | Colgate Palmolive Co | Dental preparations containing higher aliphatic acyl sarcoside compounds |
| US2909535A (en) * | 1955-03-15 | 1959-10-20 | Colgate Palmolive Co | Novel higher aliphatic acid derivatives and compositions containing the same |
| US2842479A (en) * | 1955-05-24 | 1958-07-08 | Colgate Palmolive Co | Nu-higher aliphatic acyl alpha-amino aryl acetic acids and compositions therewith |
| GB1352420A (en) * | 1971-06-18 | 1974-05-08 | Ajinomoto Kk | Arginine derivatives their production and their use |
| US4080441A (en) * | 1976-12-27 | 1978-03-21 | Colgate-Palmolive Company | Antibacterial oral composition |
| AU578392B2 (en) * | 1984-07-31 | 1988-10-20 | Lion Corporation | Toothpaste composition containing silica |
| JPS61126010A (en) * | 1984-11-20 | 1986-06-13 | Lion Corp | Composition for oral cavity application |
| JPH0720854B2 (en) * | 1986-02-20 | 1995-03-08 | ライオン株式会社 | Oral composition |
| JPH085773B2 (en) * | 1986-09-02 | 1996-01-24 | ライオン株式会社 | Oral composition |
| LU86587A1 (en) * | 1986-09-15 | 1988-04-05 | Oreal | TOOTHPASTE CONTAINING A POLY NON-IONIC SURFACTANT (HYDROXYPROPYLETHER) AND A SALT OF A SPECIFIC DERIVATIVE OF A PROTEIN DEGRADATION PRODUCT |
| DE68914386T2 (en) * | 1988-10-20 | 1994-11-17 | Ajinomoto Kk | Toothpaste-like composition. |
| JPH0825861B2 (en) * | 1989-04-24 | 1996-03-13 | サンスター株式会社 | Toothpaste composition |
| NZ235498A (en) * | 1989-10-11 | 1993-05-26 | Beecham Group Plc | Dentifrice comprising cationic antibacterial agent, non-ionic thickener, surfactant and an abrasive consisting of a sparingly soluble salt and/or an insoluble compound |
| GB9008433D0 (en) * | 1990-04-12 | 1990-06-13 | Beecham Group Plc | Novel compositions |
-
1990
- 1990-05-29 JP JP2139125A patent/JPH0684294B2/en not_active Expired - Lifetime
-
1991
- 1991-05-23 MY MYPI91000874A patent/MY106151A/en unknown
- 1991-05-23 ES ES91909703T patent/ES2078523T3/en not_active Expired - Lifetime
- 1991-05-23 CA CA002060895A patent/CA2060895C/en not_active Expired - Lifetime
- 1991-05-23 AU AU78938/91A patent/AU633217B2/en not_active Ceased
- 1991-05-23 KR KR1019910701952A patent/KR0167019B1/en not_active Expired - Fee Related
- 1991-05-23 AT AT91909703T patent/ATE126051T1/en not_active IP Right Cessation
- 1991-05-23 US US07/828,793 patent/US5266306A/en not_active Expired - Lifetime
- 1991-05-23 DE DE69111985T patent/DE69111985T2/en not_active Expired - Lifetime
- 1991-05-23 HK HK98100745A patent/HK1001670A1/en not_active IP Right Cessation
- 1991-05-23 EP EP91909703A patent/EP0485616B1/en not_active Expired - Lifetime
- 1991-05-23 DK DK91909703.0T patent/DK0485616T3/en active
- 1991-05-23 WO PCT/JP1991/000691 patent/WO1991018585A1/en not_active Ceased
- 1991-05-29 CN CN91104855A patent/CN1069189C/en not_active Expired - Fee Related
-
1995
- 1995-08-10 GR GR950401933T patent/GR3017090T3/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0485616B1 (en) | Oral composition | |
| HK1001670B (en) | Oral composition | |
| US5286479A (en) | Oral compositions for suppressing mouth odors | |
| EP0169888B1 (en) | Dental rinse | |
| EP0256566B1 (en) | Use of usnic acid or derivatives thereof in the treatment of dental caries | |
| JP2011201861A (en) | Composition for oral cavity | |
| EP0510158B1 (en) | Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and metal salts | |
| HU201464B (en) | Process for producing solution for rinsing mouth and comprising edta-sodium salt as active ingredient | |
| JP5688882B2 (en) | Liquid oral composition | |
| US4477429A (en) | Oral compositions comprising N.sup.α -alkyl derivatives of arginine | |
| JPH09286712A (en) | Composition for oral cavity | |
| US4499068A (en) | Oral compositions comprising NG -alkyl derivatives of arginine | |
| JP4452601B2 (en) | Liquid oral composition | |
| EP0976380B1 (en) | Method of recalcifying teeth | |
| JP2548265B2 (en) | Oral hygiene medicine | |
| JP2022103980A (en) | Composition for oral cavity | |
| KR100637653B1 (en) | Oral composition for bad breath | |
| JP3117086B2 (en) | Oral liquid preparation | |
| JPH0684293B2 (en) | Oral composition | |
| JPS61200905A (en) | Composition for oral cavity application | |
| JP3702428B2 (en) | Liquid oral composition | |
| WO1990010434A1 (en) | Dental preparation | |
| JPH0627062B2 (en) | Oral composition | |
| JP2848696B2 (en) | Oral liquid preparation | |
| JPH05331032A (en) | Composition for oral cavity |